2020
DOI: 10.1007/s00595-020-02051-1
|View full text |Cite
|
Sign up to set email alerts
|

Packing procedure effective for liver transplantation in hemophilic patients with HIV/HCV coinfection

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…Recently, results of liver transplantation (LT) for patients with hemophilia have been published indicating that the complication rate-especially bleeding complications-was higher in hemophiliac patients, while overall survival rate was the same as that in patients without hemophilia. 18 For hemophilia patients, meticulous hemostasis and planning for bleeding control are very important for successful LT. [19][20][21] Including LT, all HPB surgeries were performed safely and mortality and post-operative morbidity were not conspicuous. The incidence and number of complications that occurred in this series, such as blood loss, complication rate, and mortality, were too small to analyze.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, results of liver transplantation (LT) for patients with hemophilia have been published indicating that the complication rate-especially bleeding complications-was higher in hemophiliac patients, while overall survival rate was the same as that in patients without hemophilia. 18 For hemophilia patients, meticulous hemostasis and planning for bleeding control are very important for successful LT. [19][20][21] Including LT, all HPB surgeries were performed safely and mortality and post-operative morbidity were not conspicuous. The incidence and number of complications that occurred in this series, such as blood loss, complication rate, and mortality, were too small to analyze.…”
Section: Discussionmentioning
confidence: 99%
“…In Japan, our study group advocated changes in the current order of priority for the deceased donor LT (DDLT) waiting list for patients co-infected with HIV/HCV, including an increase in priority for co-infected patients in 2013 and the establishment of a scoring system for DDLT registration corresponding to the Model for End-stage Liver Disease (MELD) in 2019. 14 Recently, the introduction of the use of the direct-acting antiviral agent (DAA) for HCV has been shown to eradicate HCV hepatitis and related liver cirrhosis, even in patients with HIV [15][16][17] after LT for HCV-related liver cirrhosis. Previously, our LT patients were reinfected with HCV and became cirrhotic within 5 years; however, after the introduction of DAA, our patients attained a better overall survival after LT.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, the introduction of the use of the direct‐acting antiviral agent (DAA) for HCV has been shown to eradicate HCV hepatitis and related liver cirrhosis, even in patients with HIV 15–17 after LT for HCV‐related liver cirrhosis. Previously, our LT patients were re‐infected with HCV and became cirrhotic within 5 years; however, after the introduction of DAA, our patients attained a better overall survival after LT.…”
Section: Introductionmentioning
confidence: 99%